soul trial oral semaglutide cardiovascular outcomes nejm 2025 results In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all-cause mortality vs sitagliptin, but tirzepatide offered no additional benefit over semaglutide. https://ja.ma/3JO2SQc Curious about how much clinically studied strains Vials:1

soul trial oral semaglutide cardiovascular outcomes nejm 2025 results In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all-cause mortality vs sitagliptin, but tirzepatide offered no additional benefit over semaglutide. https://ja.ma/3JO2SQc Curious about how much clinically studied strains Vials:1

Curious about how much #protein you need while on a #glp1 journey? Read all about it! https://www.fasterwaytofatloss.com/blog-posts/glp-1-protein- calculator-daily-protein-goal-on-glp-1?aid=Aliciawhitley

12 Powell-WileyTMPoirierPBurkeLEDesprésJ-PGordon-LarsenPLavieCJet al

clinically studied strains

Vials:1

Comparing Rybelsus With Related Diabetes Options Rybelsus is an oral GLP-1 receptor agonist, while many other GLP-1 medicines are injected